Please ensure Javascript is enabled for purposes of website accessibility

Tom Stevens Podcast Transcript

Headshot of Tom Stevens

Tom Stevens Podcast Transcript

Tom Stevens joins host Brian Thomas on The Digital Executive Podcast.

Brian Thomas: Welcome to The Digital Executive. Today’s guest is Tom Stevens. As the CEO of Tombot, Tom Stevens leads a growing team of passionate and talented professionals who are dedicated to transforming the daily life of individuals, families, and communities facing mental and physical health adversities. 

Tombot designs and manufactures realistic and affordable pets for those who cannot safely or practically care for live animals due to health, cost, lifestyle choice, or living situation restrictions Well, good afternoon, Tom. Welcome to the show.  

Tom Stevens: Thank you so much. Thank you for having us, Brian.  

Brian Thomas: Absolutely. 

I appreciate it. I see there you’ve got your pet there, and I know you’ll get into that a little bit more, but thank you so much. I appreciate that. You’re hailing out of the Los Angeles area, Santa Clarita. I’m in Kansas City, so I appreciate you making the time. And let’s just jump in- Thank you … Tom, your backstory. 

Your mother’s Alzheimer’s diagnosis meant that you had to rehome her dog. So how did that experience, after thirty-five years in the high-tech, lead you to found Tombot?  

Tom Stevens: Thank you for asking. Yes, my mom’s story was really tough. So I’ve spent my entire career in high-tech. My two Tombot co-founders and I built a prior startup into one of the world’s largest litigation automation companies. 

We were successfully acquired, which gave me the freedom to think about other things. Unfortunately, that same year, my mother was diagnosed with Alzheimer’s dementia. I had to take over her life and make a number of really tough decisions on her behalf, by far the worst of which was realizing I had to take away her dog for safety reasons. 

She was quite unhappy with me. I looked around for substitutes for live animal companions. She didn’t like anything that I brought home, and I realized then that there might be a large unmet need. Really just out of interest in salvaging my relationship with my mom, I embarked on what became a multi-year research and education journey, culminating in a master’s degree from Stanford University, and along the way, I learned that my mom’s story is shared by over three hundred million seniors with dementia or pre-dementia, mild cognitive impairment. 

In about half the planet, about one billion of the two billion households don’t keep live animals as pets for reasons including health adversity, cost, burden of care, and living restrictions. And so we launched Tombot to be in service to those people. Our first product to market, Jennie, was designed specifically for seniors with dementia. 

Seniors with dementia suffer from something called behavioral and psychological symptoms, which include loneliness, anxiety, depression, delirium. In my mother’s case, hallucinations and violent anger. To, to manage those symptoms, doctors historically have relied upon psychotropic medications, and while you or I would likely tolerate those medications without too much trouble, they’re very hard on the elderly, so much that the Centers for Medicare and Medicaid Services now prohibit their use in long-term care under most circumstances. 

This is a very well-researched area. There are dozens of peer-reviewed studies going back as many as forty years that show that where a senior with dementia can form a robust emotional attachment to an object, traditionally that object’s been a human baby doll or a stuffed animal. That senior gets a great deal of relief from those behavioral and psychological symptoms and a corresponding reduction in need for those psychotropic medications. 

The problem, however, most seniors are like my mother, and they don’t care for those traditional objects. Research on robotic animals show they significantly outperform the traditional objects and have the added benefit of reducing pain and the need for pain medications. The problem there, however, are existing technologies are either simple children’s toys, which have been rebranded for seniors, and once the novelty effect wears off, most seniors lose interest in them, or on the other end of the spectrum are prohibitively expensive robots. 

This whole space was invented in the early two thousands by a Japanese research institute. They created a robotic seal by the name of Paro. Paro is a good robot, but it costs about seven thousand dollars. Most senior care facilities can’t justify that expense, let alone individuals like my mother who need one for themselves in order to form that emotional bond. 

It actually wasn’t our mission to develop a robotic puppy. It was our mission to develop a better emotional attachment object, one that consistently stimulates enduring emotional attachment, but also be available at a price that many people could afford, even while we’re still working on getting healthcare insurance reimbursements in place. 

We did formal studies with over seven hundred seniors with dementia. We were supported by researchers from the University of Illinois and Georgia Tech. And with their help, we learned a great deal, but the biggest takeaways were around realism. Realism, first of all, in objects in which they’re already familiar, so puppies and kittens as opposed to wild animals or fictitious creatures. 

And then secondly, the more realistic, the better. Realism in appearance, in texture, most importantly, realism in behaviors. We teamed up with Jim Henson’s Creature Shop to do our artistic design, and with their help, we’re building what we believe to be the world’s most realistic robotic animals. They’re scientifically designed to stimulate emotional attachment and makes us the first puppies to be both FDA medical devices and remote safety and health monitoring platforms  

Brian Thomas: Wow. 

Th- that’s just amazing. I, I love the backstory because that, again, you hit a challenge in your life, and it was very personal, and, and I appreciate you sharing that with us. But to go through all of that research, labor, R&D to get to something that now is gonna be approved as a, as an FDA medical device is just simply amazing. 

So I appreciate that backstory, really do. And I wanna jump in, Tom, to your next question because you can start to dive into some of the, the things around what you’re trying to build. You worked with, again, Jim Henson’s Creature Shop, you talked about that, to make Jenny look like a real Labrador puppy. 

So what did they teach you about creating an emotional bond with a robot?  

Tom Stevens: Well, first of all, these are not just tremendous artists, these are wonderful human beings. It’s such a treat to be able to work with them. The core team at Tombot were a bunch of roboticists. We h- we knew how to make a robot, but not how to make a robot look and behave like a real dog. 

And so we reached out to the animatronics community, and I threw Jim Henson’s Creature Shop into the list of companies that we reached out to just saying, “Hey, I, I… That’s the one name I recognize on the list,” not thinking they would have any interest in it at all. Turns out the two leads on our project, the, the creative director and the animatronics supervisor, both had dads in late-stage dementia. 

They said, “We don’t care. We wanna work on this project whatever it takes.” And so we not only got a chance to tap into the wonderful creative work that brought us Muppets, Sesame Street, and, and many realistic TV and film props, we got these great human beings that, that really had a personal connection into our mission and went above and beyond to create just a really compelling series of prototypes so that we could you could really evaluate what the seniors wanted. 

Y- and, and their background really is puppets. they, they made Muppets as puppets and Sesame Street characters as puppets. They understand how things move. They understand how to make something that’s artificial be really heartwarming and compelling. Without them, we wouldn’t have gotten there. 

Just a tremendous tremendous teammate that we have, and our relationship is ongoing.  

Brian Thomas: That’s amazing. And you’re really working with some world cra- cl- world-class people there. I mean, who… Where else can you get that same love and attention and emotion that they have put all, over the years into these, you know, we grew up with them, into these Muppets or puppets, and now you’re, they’re really transforming elderly lives that people are, that have been diagnosed like your mother with Alzheimer’s. 

So I appreciate that. And Tom, with TomBot seeking FDA medical device status for, for Jenny, what are the hardest parts of meeting regulator standards while building a consumer product people love?  

Tom Stevens: It, it, great question. This is not for the faint of heart. There’s a reason why products most consumer products are not FDA products, is it’s just a really difficult path regulatory path to go through. 

So our classification would be a class II 510exempt product, which means that we don’t have to do pre-market clinical studies before we can start shipping as a, as an FDA product. But we do have significant compliance requirements, both in terms of supply chain management and good manufacturing practices, but also from a safety standpoint. 

Medical devices have very high standards of safety, and so, they’re called IEC safety requirements. There’s an extensive list of, of tests that your product has to be able to pass, not just to not just to make sure that it can’t injure somebody in regular use, but when it breaks, it doesn’t injure somebody. 

So small pieces can’t come off of it, sharp edges or sharp points can’t emerge. ‘Cause these, these products aren’t stationary. I mean, literally they’re stationary. She doesn’t walk, but she’s on somebody’s lap, or she’s in a bed with them. She’s in a, a recliner with them. They’re gonna fall a lot. They’re gonna hit the floor, and if things break, we have to make sure that they break in a safe manner. 

So it’s, it’s a very, very high bar  

Brian Thomas: Absolutely. And Tom, I, my background y- although in tech, I worked with a lot of medical devices because I worked in healthcare for so many years, and I totally get that. The standards there are very, very high, and I appreciate you sharing the fact that you have to build something that’s very rugged, and if it does happen to break, it’s not gonna cause any additional harm. 

So I, I appreciate, again, going through the motions to get something approved is, is just intense there with the FDA, so thank you. And Tom, last question of the day, as we look ahead to the future, how do you see AI, robotics, and mental healthcare coming together over the next decade, and where will companion robots fit in? 

Tom Stevens: I love the question. First of all, behavioral health is undertreated in the United States. It’s undertreated around the world, but it’s, it’s, it’s at crisis levels of undertreatment here in the US, in part because talking about mental health and behavioral health has carried such stigma over the years. 

And certainly people from my generation, we’re perfectly happy to tell you some fun story about how we broke our leg, but we’re not gonna tell you that I didn’t sleep a lot last night ’cause I have severe anxiety, or I couldn’t make it into work today ’cause I’m severely depressed. These are things that because it’s difficult to discuss, it’s difficult to discuss them with healthcare professionals, it’s difficult to be compliant or adherent with with follow-up. 

Because of that there’s just a lot of people that suffer from from these serious conditions. It’s thought that as many as 60 million American adults have severe anxiety or depression or both severe meaning that it affects them on a daily basis and is, has been affecting them for a minimum of six months. 

So 60 million, 60 million American adults. Where, where I expect companion robots to go, and certainly where TomBot’s mission is, is to treat or to provide solutions for people with behavioral health challenges and also monitor them for safety and health. One of the ch- early challenges I realized with my mother after she was diagnosed with dementia is she lost her ability to act as her own patient advocate with, with the doctors. 

I would take her to a doctor’s visit. The doctor would ask her, you know, “How have you been since the last time?” I saw you,” and she would say, “Fine.” And of course, she hadn’t been fine. She had fallen a few times. She had, she had had some recurring infections. She had had all kinds of things that were going on with her, but she had lost her ability to, to remember those. 

First of all, classify them, remember them, and report them effectively, and I couldn’t look at her every minute of the day. I didn’t… I, I had some conceptual things, but I couldn’t give an accurate report. And so being able to monitor this the person for safety and for health, give better information for the individual, but also to the medical providers so they get better diagnoses and better treatment courses more effective treatment courses right away without this sort of back and forth trial and error that so many people with mental or behavioral health challenges go through. 

Brian Thomas: Thank you, and you highlighted some great things. Obviously, the health and safety and wellbeing of the person or the patient whatever it is, whether they have advanced stages of Alzheimer’s or, or maybe it’s just people suffering with as you said, behavioral health issues. And having some- something there to monitor that’s medically grade and, and it will be able to report on those things is, is phenomenal. 

It really is, and it’s gonna help paint a better picture when they do see their health providers. So really appreciate that. And Tom, it was such a pleasure having you on today, and I look forward to speaking with you real soon.  

Tom Stevens: Well, Brian, thank you so much for having us. Anybody has more information, you can find us on the web at tombot.com, T-O-M-B-O-T.com, and please feel free to reach out. 

We’re, we’re thrilled to talk to anybody who wants to talk to us.  

Brian Thomas: Awesome. Bye for now.

Tom Stevens Podcast Transcript. Listen to the audio on the guest’s Podcast Page.

Subscribe

* indicates required